| Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Dec'15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||||||
Current assets | |||||||||||||
Cash and cash equivalents | |||||||||||||
2,140 | 1,895 | 636 | 1,340 | 479 | 316 | 386 | 732 | 1,201 | 1,752 | 5,189 | 7,141 | 7 | 5 |
Restricted cash | |||||||||||||
636 | 459 | 16 | 16 | 15 | 17 | 16 | 5 | 6 | - | - | - | 0 | - |
Marketable securities | |||||||||||||
12,699 | 7,485 | 11,007 | 6,542 | 2,573 | 4,549 | 6,342 | 8,304 | 606 | 2,005 | - | - | 0 | - |
Right-of-use lease assets | |||||||||||||
66 | 58 | - | - | - | - | - | - | - | - | - | - | - | - |
Right-of-use asset | |||||||||||||
- | - | 69 | - | - | - | - | - | - | - | - | - | - | - |
Other current assets and prepaid expenses | |||||||||||||
429 | 414 | 545 | 788 | 85 | 124 | 116 | 59 | 109 | - | - | - | 78 | - |
Other current assets | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Other accounts receivable and prepaid expenses | |||||||||||||
- | - | - | - | - | - | - | - | - | 114 | 187 | 177 | - | - |
Total current assets | |||||||||||||
15,972 | 10,312 | 12,274 | 8,688 | 3,154 | 5,006 | 6,860 | 9,101 | 1,922 | 3,871 | 5,376 | 7,318 | 85 | 5 |
Licensed right to use technology | |||||||||||||
422 | 431 | 441 | 495 | - | - | - | - | - | - | - | - | - | - |
Right-of-use lease assets | |||||||||||||
145 | 169 | 174 | - | - | - | - | - | - | - | - | - | - | - |
Licensing right to use technology | |||||||||||||
- | - | - | - | 495 | - | - | - | - | - | - | - | - | - |
Deferred private placement costs | |||||||||||||
- | - | - | - | - | - | 0 | - | 0 | 0 | 0 | 0 | 90 | - |
Property and equipment, net | |||||||||||||
216 | 228 | 230 | 244 | 259 | 259 | 239 | 253 | 267 | 208 | 116 | 80 | 61 | - |
Total non-current assets | |||||||||||||
- | - | - | - | - | - | 239 | - | 267 | 208 | 116 | 80 | 151 | - |
TOTAL ASSETS | |||||||||||||
16,756 | 11,143 | 13,120 | 9,428 | 3,909 | 5,265 | 7,099 | 9,355 | 2,189 | 4,079 | 5,492 | 7,398 | 236 | 5 |
LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||||
Current liabilities | |||||||||||||
Accounts payable | |||||||||||||
2,013 | 2,104 | 1,553 | 1,164 | 833 | 862 | - | 842 | - | - | - | - | - | 0 |
Other current liabilities | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Note payable - related party | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Accrued expenses | |||||||||||||
1,675 | 2,068 | 1,514 | 1,567 | 324 | 347 | - | 1,257 | - | - | - | - | - | 0 |
Deferred revenue | |||||||||||||
675 | 990 | 1,635 | 2,263 | - | - | - | - | - | - | - | - | - | - |
Stock to be issued to a vendor | |||||||||||||
156 | 138 | 166 | 144 | - | - | - | - | - | - | - | - | - | - |
Operating lease liability | |||||||||||||
67 | 65 | 63 | - | - | - | - | - | - | - | - | - | - | - |
Options to be issued to NitricGen | |||||||||||||
- | - | - | - | 295 | - | - | - | - | - | - | - | - | - |
Bank loan | |||||||||||||
- | - | - | - | - | - | 0 | - | 0 | 0 | 0 | 27 | 39 | - |
Trade payables | |||||||||||||
- | - | - | - | - | - | 755 | - | 669 | 463 | 440 | 548 | 528 | - |
Other accounts payable | |||||||||||||
- | - | - | - | - | - | 726 | - | 694 | 633 | 477 | - | 1,093 | - |
Other accounts payable | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | 857 | - | - |
Loans from related parties and others | |||||||||||||
- | - | - | - | - | 34 | 34 | 33 | 33 | 30 | 28 | 208 | 379 | - |
Loan payable | |||||||||||||
- | 88 | 147 | 263 | - | - | - | - | - | - | - | - | - | - |
Total current liabilities | |||||||||||||
4,589 | 5,454 | 5,080 | 5,403 | 1,453 | 1,243 | 1,515 | 2,132 | 1,396 | 1,126 | 945 | 1,640 | 2,039 | 0 |
Long-term liabilities | |||||||||||||
Operating lease liability | |||||||||||||
151 | 169 | 179 | - | - | - | - | - | - | - | - | - | - | - |
Liabilities related to warrants | |||||||||||||
- | - | - | - | - | 9,029 | 6,955 | 5,677 | 9,172 | 9,819 | 4,735 | 4,886 | 0 | - |
Note payable - related party | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 10 |
Accrued interest - related party | |||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | - | 0 |
Convertible notes | |||||||||||||
- | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 2,895 | - |
Total non-current liabilities | |||||||||||||
- | - | - | - | - | - | - | - | - | 9,819 | 4,735 | 4,886 | - | - |
Total liabilities | |||||||||||||
4,740 | 5,623 | 5,260 | 5,403 | 1,453 | 10,272 | 8,470 | 5,677 | 10,568 | 10,945 | 5,680 | 6,526 | 4,934 | 10 |
Commitments and contingencies | |||||||||||||
- | - | - | - | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 | - |
Shareholders' equity | |||||||||||||
Preferred Stock, $0.0001 par value per share: 10,000,000 shares authorized, 0 shares issued and outstanding | |||||||||||||
- | - | - | - | - | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock, $0.0001 par value per share: 100,000,000 shares authorized, 13,901,745 and 8,714,815 shares issued and outstanding as of December 31, 2019 and March 31, 2019, respectively | |||||||||||||
1 | 1 | 1 | 0 | 0 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Treasury stock | |||||||||||||
25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 0 | - |
Additional paid-in capital | |||||||||||||
64,358 | 53,466 | 51,709 | 41,693 | 40,056 | 33,044 | 32,221 | 32,141 | 23,260 | 23,038 | 22,572 | 20,752 | 8,874 | 5 |
Accumulated deficit | |||||||||||||
-52,318 | -47,923 | -43,825 | -37,644 | -37,586 | -38,033 | -33,570 | -30,569 | -31,617 | -29,885 | -22,736 | -19,856 | -13,573 | -10 |
Accumulated other comprehensive loss | |||||||||||||
- | - | - | - | 10 | 5 | 2 | -2 | 2 | 5 | - | - | 0 | - |
Total shareholders' equity | |||||||||||||
12,016 | 5,519 | 7,860 | 4,024 | 2,455 | -5,007 | -1,371 | 1,544 | -8,379 | -6,866 | -188 | 872 | -4,698 | -5 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | |||||||||||||
16,756 | 11,143 | 13,120 | 9,428 | 3,909 | 5,265 | 7,099 | 9,355 | 2,189 | 4,079 | 5,492 | 7,398 | 236 | 5 |